Tristetraprolin limits inflammatory cytokine production in tumor-associated macrophages in an mRNA decay-independent manner

Cancer Research

Volumn 75, Issue 15, 2015, Pages 3054-3064

  Kratochvill, Franz ^a   Gratz, Nina ^a   Qualls, Joseph E ^a   Van De Velde, Lee Ann ^a   Chi, Hongbo ^a   Kovarik, Pavel ^b   Murray, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 14; TRISTETRAPROLIN; AUTACOID; ZFP36 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; IN VITRO STUDY; INFLAMMATION; MOUSE; MRNA DECAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA METABOLISM; RNA STABILITY; RNA TRANSLATION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENETICS; MACROPHAGE; METABOLISM; PATHOLOGY; RNA PROCESSING; TRANSGENIC MOUSE;

ANIMALS; CYTOKINES; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 14; NEOPLASMS, EXPERIMENTAL; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; TRISTETRAPROLIN;

EID: 84942832431     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0205     Document Type: Article

References (36)

1. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140: 871-82.
2. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12: 253-68.
3. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009; 138: 129-45.
4. Danko CG, Hah N, Luo X., Martins AL, Core L, Lis JT, et al Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol Cell 2013; 50: 212-22.
5. Bhatt DM, Pandya-Jones A, Tong A.J., Barozzi I., Lissner MM, Natoli G, et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 2012; 150: 279-90.
6. Carballo E, Lai WS, Blackshear PJ Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998; 281:1001-5.
7. Schaljo B, Kratochvill F, Gratz N., Sadzak I, Sauer I, Hammer M., et al. Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10. J Immunol 2009; 183: 1197-206.
8. Mahtani KR, Brook M, Dean J.L., Sully G., Saklatvala J, Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 2001; 21: 6461-9.
9. Stoecklin G, Stubbs T, Kedersha N., Wax S, Rigby WF, Blackwell T.K., et al. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 2004; 23: 1313-24.
10. Brook M, Tchen CR, Santalucia T, McIlrath J., Arthur JS, Saklatvala J, et al. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 2006; 26: 2408-18.
11. Gaba A, Grivennikov SI, Do M.V., Stumpo DJ, Blackshear PJ, Karin M. Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production. J Immunol 2012; 189: 2089-93.
12. Hammer M, Mages J, Dietrich H., Servatius A, Howells N, Cato A.C., et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 2006; 203:15-20.
13. Taylor GA, Carballo E, Lee D.M., Lai WS, Thompson MJ, Patel DD, et al A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996; 4: 445-54.
14. Molle C, Zhang T, Ysebrant de Lendonck L, Gueydan C, Andrianne M, Sherer F, et al. Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease. J Exp Med 2013; 210:1675-84.
15. Kratochvill F, Machacek C, Vogl C., Ebner F, Sedlyarov V, Gruber A.R., et al. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation. Mol Syst Biol 2011; 7: 560.
16. Nishida K, Yamaguchi O, Hirotani S., Hikoso S, Higuchi Y, Watanabe T., et al. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol 2004; 24: 10611-20.
17. Weiss WA, Aldape K, Mohapatra G., Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997; 16: 2985-95.
18. Walkley CR, Qudsi R, Sankaran V.G., Perry JA, Gostissa M, Roth SI, et al Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008; 22: 1662-76.
19. Stables MJ, Shah S, Camon E.B., Lovering RC, Newson J, Bystrom J, et al Transcriptomic analyses of murine resolution-phase macrophages. Blood 2011; 118: e192-208.
20. Kawauchi D, Robinson G, Uziel T., Gibson P, Rehg J, Gao C., et al. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 2012; 21: 168-80.
21. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99.
22. Movahedi K, Laoui D, Gysemans C., Baeten M, Stange G, Van den Bossche J, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010; 70: 5728-39.
23. O'Sullivan T., Saddawi-Konefka R, Vermi W., Koebel CM, Arthur C, White JM, et al Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med 2012; 209: 1869-82.
24. Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S., Jansson O, Grip O, et al Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 2013; 6: 498-510.
25. Lai WS, Carrick DM, Blackshear PJ Influence of nonameric AU-rich tristetraprolin-binding sites on mRNA deadenylation and turnover. J Biol Chem 2005; 280: 34365-77.
26. Tudor C, Marchese FP, Hitti E, Aubareda A., Rawlinson L, Gaestel M, et al The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett 2009; 583: 1933-8.
27. Stoecklin G, Tenenbaum SA, Mayo T, Chittur S.V., George AD, Baroni TE, et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 2008; 283: 11689-99.
28. Schichl YM, Resch U, Hofer-Warbinek R, de Martin R. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J Biol Chem 2009; 284: 29571-81.
29. Hammer M, Mages J, Dietrich H., Schmitz F, Striebel F, Murray P.J., et al. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol 2005; 35: 2991-3001.
30. Chakraborty M, Lou C, Huan C., Kuo MS, Park TS, Cao G, et al Myeloid cell-specific serine palmitoyltransferase subunit 2 haploin-sufficiency reduces murine atherosclerosis. J Clin Invest 2013; 123: 1784-97.
31. Chi H, Barry SP, Roth R.J., Wu JJ, Jones EA, Bennett AM, et al Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A 2006; 103:2274-9.
32. Zhao Q, Wang X, Nelin L.D., Yao Y., Matta R, Manson ME, et al MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 2006; 203: 131-40.
33. Wagner EF, Nebreda AR Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9: 537-49.
34. Lai WS, Carballo E, Strum J.R., Kennington EA, Phillips RS, Blackshear PJ. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999; 19: 4311-23.
35. Tiedje C, Ronkina N, Tehrani M., Dhamija S, Laass K, Holtmann H., et al. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet 2012; 8: e1002977.
36. Chan JK, Roth J, Oppenheim J.J., Tracey KJ, Vogl T, Feldmann M, et al Alarmins: awaiting a clinical response. J Clin Invest 2012; 122: 2711-9.